163 related articles for article (PubMed ID: 37365600)
1. Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancer.
Farhang Ghahremani M; Seto KKY; Cho W; Miller MC; Smith P; Englert DF
J Transl Med; 2023 Jun; 21(1):414. PubMed ID: 37365600
[TBL] [Abstract][Full Text] [Related]
2. Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization.
Cohen EN; Jayachandran G; Hardy MR; Venkata Subramanian AM; Meng X; Reuben JM
PLoS One; 2020; 15(10):e0241123. PubMed ID: 33095819
[TBL] [Abstract][Full Text] [Related]
3. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
[TBL] [Abstract][Full Text] [Related]
5. A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix
Cohen EN; Jayachandran G; Moore RG; Cristofanilli M; Lang JE; Khoury JD; Press MF; Kim KK; Khazan N; Zhang Q; Zhang Y; Kaur P; Guzman R; Miller MC; Reuben JM; Ueno NT
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358657
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance of the FDA-cleared Parsortix
Templeman A; Miller MC; Cooke MJ; O'Shannessy DJ; Gurung Y; Pereira T; Peters SG; Piano M; Teo M; Khazan N; Kim K; Cohen E; Lopez HB; Alvarez F; Ciccioli M; Pailhes-Jimenez AS
J Circ Biomark; 2023; 12():26-33. PubMed ID: 37601320
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
Chudziak J; Burt DJ; Mohan S; Rothwell DG; Mesquita B; Antonello J; Dalby S; Ayub M; Priest L; Carter L; Krebs MG; Blackhall F; Dive C; Brady G
Analyst; 2016 Jan; 141(2):669-78. PubMed ID: 26605519
[TBL] [Abstract][Full Text] [Related]
8. Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Ring A; Campo D; Porras TB; Kaur P; Forte VA; Tripathy D; Lu J; Kang I; Press MF; Jeong YJ; Snow A; Zhu Y; Zada G; Wagle N; Lang JE
Ann Surg Oncol; 2022 May; 29(5):2882-2894. PubMed ID: 35000083
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of circulating tumor cells in metastatic breast cancer.
Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer.
Groen L; Kloots I; Englert D; Seto K; Estafanos L; Smith P; Verhaegh GW; Mehra N; Schalken JA
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240349
[TBL] [Abstract][Full Text] [Related]
13. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
14. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of circulating tumor cells in breast cancer.
Fina E; Callari M; Reduzzi C; D'Aiuto F; Mariani G; Generali D; Pierotti MA; Daidone MG; Cappelletti V
Clin Chem; 2015 Jan; 61(1):278-89. PubMed ID: 25411184
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
[TBL] [Abstract][Full Text] [Related]
17. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.
Magbanua MJ; Pugia M; Lee JS; Jabon M; Wang V; Gubens M; Marfurt K; Pence J; Sidhu H; Uzgiris A; Rugo HS; Park JW
PLoS One; 2015; 10(10):e0141166. PubMed ID: 26496203
[TBL] [Abstract][Full Text] [Related]
18. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery.
Payne K; Brooks JM; Taylor GS; Batis N; Noyvert B; Pan Y; Nankivell P; Mehanna H
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771681
[TBL] [Abstract][Full Text] [Related]
19. Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer.
Fernandez-Garcia D; Nteliopoulos G; Hastings RK; Rushton A; Page K; Allsopp RC; Ambasager B; Gleason K; Guttery DS; Ali S; Charles Coombes R; Shaw JA
Br J Cancer; 2022 Nov; 127(10):1858-1864. PubMed ID: 36088510
[TBL] [Abstract][Full Text] [Related]
20. Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).
Magbanua MJM; Rugo HS; Wolf DM; Hauranieh L; Roy R; Pendyala P; Sosa EV; Scott JH; Lee JS; Pitcher B; Hyslop T; Barry WT; Isakoff SJ; Dickler M; Van't Veer L; Park JW
Clin Cancer Res; 2018 Mar; 24(6):1486-1499. PubMed ID: 29311117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
